You are a PE sponsor, operating partner, board member or mid-market CEO looking at a portfolio company where the investment thesis depends on faster, cleaner revenue growth. The product may be sound. The market may be real. But the GTM motion is uneven: sales cycles drift, pipeline quality is debatable, marketing is hard to attribute, the CRM is not trusted, and the management meeting produces anecdotes rather than decisions.
That is the practical context behind GTM value creation for portfolio companies. It is not a branding exercise and it is not another slide on growth levers. It is the work of turning commercial ambition into an operating system: who you sell to, why they buy, how leads are created, how pipeline is qualified, how pricing is governed, how handoffs work, and how the sponsor sees progress before the next board meeting.
In my experience, the strongest results come when GTM is treated as an operating discipline, not a departmental project owned only by sales or marketing. Revenue growth usually breaks at the seams: marketing generates the wrong demand, sales accepts it because the quarter is short, customer success inherits weak-fit accounts, finance discounts without a policy, and product hears the feedback too late. The value creation work is stitching those seams back together.
What buyers actually mean by GTM value creation for portfolio companies
When someone searches for this term, they usually mean one of five things.
- A post-close growth plan. The deal is complete, the first 100 days are moving fast, and the sponsor needs a credible commercial roadmap beyond generic cross-sell, upsell and pricing language.
- A revenue diligence follow-through. The diligence memo flagged pipeline conversion, low CRM hygiene, channel dependency or poor sales productivity. Now someone has to turn that into operating actions.
- A stalled portfolio company. The company has hit a ceiling: founder-led sales no longer scales, marketing spend is not converting, or enterprise deals are taking twice as long as forecast.
- A RevOps cleanup. Salesforce, HubSpot, billing, product analytics and CS tools do not agree. Board reporting is slow and every number requires manual reconciliation.
- A commercial transformation without a full executive hire. The company needs senior pattern recognition now, but may not yet need a permanent CRO, CMO or Chief Revenue Officer structure.
Those are different problems. The mistake is treating them with the same answer: hire more reps, buy another tool, refresh messaging, or ask marketing for more MQLs. GTM value creation only works when the intervention matches the constraint.
The question is not, ‘How do we grow revenue?’ The useful question is, ‘Which part of the revenue system is currently limiting growth, and what evidence proves it?’
The portfolio GTM problem is usually cross-functional
Most portfolio GTM issues do not sit neatly inside one function. I often see sponsors start with a sales productivity question and end up finding a pricing, positioning or implementation problem. A few common patterns:
- ICP drift. The company serves too many segments because historical growth came from saying yes. The team cannot define the best-fit customer without listing half the market.
- Pipeline inflation. The CRM looks healthy, but late-stage opportunities have no compelling event, no economic buyer, or no close plan.
- Discount leakage. Reps negotiate from habit, not from a pricing architecture. Finance sees the margin damage after the deal is signed.
- Channel ambiguity. Partners, resellers, marketplaces or agencies exist, but ownership, attribution and enablement are weak.
- Marketing misalignment. Campaigns are judged by activity metrics while sales complains about lead quality. Neither side owns revenue learning.
- Customer expansion is under-run. The base has potential, but onboarding, adoption, QBRs and product packaging do not create repeatable upsell moments.
The value creation agenda should convert those patterns into a short list of accountable moves. If everything is a priority, the portfolio company gets a theatre of action: more dashboards, more meetings, more initiatives, and no real operating change.
A decision framework for choosing the right GTM intervention
I use a simple sequence before recommending work. It keeps sponsors and CEOs from over-prescribing the solution too early.
1. Define the growth thesis in operational terms
Start with the investment thesis, but translate it into operating hypotheses. Is the plan based on winning larger accounts, improving retention, raising price, expanding internationally, cross-selling into the installed base, or moving from founder-led sales to a repeatable team model? Each thesis demands different GTM machinery.
If the thesis says ‘enterprise expansion’, I want to see whether the company has enterprise proof: procurement readiness, security responses, implementation capacity, customer references, ROI narrative and sales cycle discipline. If the thesis says ‘pricing upside’, I want to see discount history, willingness-to-pay evidence, packaging, competitive anchors and churn sensitivity.
2. Separate demand, conversion and monetisation
Revenue problems get misdiagnosed when all growth metrics are mashed together. I separate the system into three layers:
- Demand: enough of the right people enter the funnel from the right sources.
- Conversion: those opportunities move through a defined process with real qualification and urgency.
- Monetisation: the company captures sufficient price, margin, expansion and retention.
A demand problem needs segmentation, positioning, channel strategy and campaign focus. A conversion problem needs sales process, qualification, enablement and deal governance. A monetisation problem needs pricing, packaging, customer success and commercial policy. Mixing these up wastes months.
3. Check the data before trusting the dashboard
In portfolio work, the dashboard often looks more precise than it is. Before using CRM conversion rates, CAC payback, pipeline coverage or win-rate trends, I want to know how the data is entered, who owns definitions, which fields are mandatory, and whether finance can reconcile bookings, revenue and churn against the commercial tools.
This is where RevOps becomes central. RevOps is not just tool administration. It is the operating layer that lets management make decisions about pipeline, capacity, pricing, retention and forecast risk. If the definitions are weak, the GTM plan rests on sand.
4. Identify the limiting constraint
The strongest GTM value creation plans pick one or two constraints to attack first. Examples: poor-fit inbound volume, weak outbound list quality, no vertical positioning, slow proposal turnaround, discounting without approval, insufficient sales manager inspection, low onboarding adoption, or no expansion playbook.
The answer may be unglamorous. A better stage-exit criterion in the CRM can do more for forecast quality than a new marketing campaign. A pricing approval matrix can protect margin faster than a rebrand. A clear ICP exclusion list can improve productivity more than hiring five more reps.
5. Build a 30, 60 and 100-day cadence
The first 100 days matter because the organisation is still listening. I like a plan that defines what will be diagnosed, decided and implemented by each milestone. Not everything will be solved in 100 days, but the company should know what is changing, who owns it, and how the board will see progress.
Short comparison of GTM value creation options
There is no single right delivery model. The right choice depends on urgency, internal capability and the nature of the constraint.
- Internal management team only. Best when the CEO, CRO, CMO and RevOps leader already agree on the diagnosis and have capacity to execute. Lowest external cost, but often slow if there are functional politics or blind spots.
- Operating partner-led sprint. Best when the sponsor needs a rapid outside-in view and a practical action plan. Strong for post-close prioritisation, board alignment and forcing clarity across functions.
- Fractional revenue or technology advisor. Best when the company needs sustained senior judgement, weekly cadence and a second opinion for management without hiring a full-time executive too early.
- Specialist agency or RevOps implementer. Best when the diagnosis is clear and the work is execution-heavy: CRM rebuild, attribution setup, content production, paid media management or sales enablement assets.
- Permanent CRO, CMO or RevOps leader hire. Best when the business has the scale, budget and organisational need for long-term ownership. It is slower and higher commitment, but often necessary once the operating model is proven.
My bias is to avoid hiring or tooling as the first move unless the constraint is already obvious. A portfolio company can easily spend six months recruiting a senior leader for a problem that was actually segmentation, pricing governance or poor data discipline.
The GTM value creation playbooks that usually matter
The named playbooks vary by company, but these are the ones I reach for most often.
ICP and segmentation reset
This is the foundation. Define the best-fit segments, the accounts to de-prioritise, the buyer committee, the pain trigger, and the commercial reason to focus. A useful ICP is not a persona poster. It changes sales routing, campaign spend, product feedback and customer success coverage.
Pipeline quality and deal inspection
Install stage definitions, exit criteria, MEDDICC-style qualification where appropriate, next-step discipline, close plans for larger deals, and weekly manager inspection. The point is not bureaucracy. The point is to stop treating hope as pipeline.
Pricing and packaging governance
Review packaging, discount history, approval thresholds, competitor anchors, renewal behaviour and expansion paths. Many mid-market companies have enough pricing leakage to justify immediate attention, but the work must be grounded in customer value and churn risk, not spreadsheet optimism.
RevOps operating model
Clarify definitions for lead, MQL, SQL, opportunity, pipeline, booking, ARR, churn, expansion and forecast category. Then align CRM fields, dashboards, handoffs and meeting cadence. If the weekly revenue meeting cannot make decisions from the data, the RevOps system is not yet operating.
Expansion and retention motion
For many portfolio companies, the cheapest growth is not cheap, but it is closer: existing customers. The playbook covers onboarding, adoption signals, health scores, renewal process, executive touchpoints, expansion triggers and product packaging that supports account growth.
What good board reporting looks like
For sponsors, GTM value creation has to show up in board materials without becoming a vanity dashboard. I prefer a small set of metrics tied to the thesis:
- Pipeline created by target segment and source.
- Pipeline quality by stage, age and next step.
- Win rate and sales cycle by segment or motion.
- Average selling price, discount rate and gross margin impact.
- Net retention, renewal risk and expansion pipeline.
- Sales capacity, ramp status and productivity by cohort.
- Forecast accuracy and reasons for slippage.
The key is not the number of charts. It is whether the management team can explain what changed, what they learned, what decision they need, and which constraint they are attacking next.
When GTM value creation is the wrong tool
GTM work is powerful, but it is not a cure for every portfolio problem. There are situations where pushing harder on GTM is the wrong move.
- The product does not deliver the promised value. Better sales execution can create more disappointed customers. Fix adoption, reliability or implementation first.
- The market is too narrow for the thesis. GTM discipline cannot manufacture a large addressable market where one does not exist.
- The company lacks delivery capacity. If operations cannot support new sales, growth will damage retention and margin.
- The CEO and sponsor are not aligned. GTM value creation requires tradeoffs. Without alignment, the work becomes performative.
- The business needs restructuring before growth. If cash, debt covenants or severe operational issues dominate, a growth programme may be premature.
- The team wants validation, not change. A GTM review that cannot change territories, pricing, process, roles or spend is just theatre.
I am blunt about this because misapplied GTM programmes create organisational fatigue. People sit in workshops, dashboards multiply, and the underlying bottleneck remains untouched. Sometimes the right answer is product remediation, customer delivery, leadership change, or a narrower strategic reset before commercial acceleration.
Common mistakes sponsors and CEOs should avoid
- Starting with tooling. A new CRM configuration will not fix an unclear ICP or weak sales management cadence.
- Equating activity with progress. More outbound, more content and more meetings can hide poor targeting.
- Over-hiring before the motion is proven. Additional reps amplify the current system. If the system is broken, they amplify waste.
- Ignoring customer success. Expansion, retention and referenceability are part of GTM, not a post-sale afterthought.
- Letting each function optimise locally. Marketing, sales, product, finance and CS need shared definitions and shared consequences.
The pattern I see is simple: portfolio companies do not usually lack ambition. They lack a constrained, sequenced operating agenda. The sponsor asks for growth, the CEO pushes the team, each function launches initiatives, and the board receives a longer update with too little decision-quality signal.
How I would approach this
If I were advising the sponsor or sitting alongside the CEO, I would start with a short diagnostic around the investment thesis, the current GTM motion and the evidence behind the revenue plan. I would not begin by prescribing a CRO hire, agency brief or CRM rebuild. First I would isolate the constraint.
The working session would cover ICP, pipeline quality, pricing and packaging, channel performance, RevOps definitions, retention and expansion, management cadence, and board reporting. From there I would produce a tight set of decisions: what to stop, what to fix now, what to sequence over the next 100 days, and what requires leadership or execution capacity.
Where the company needs a post-close plan, the natural next step is a 100-Day Value Creation Plan. Where the sponsor or CEO needs an ongoing second opinion across RevOps, GTM, technology and execution tradeoffs, I would use a Fractional Retainer. DevriX can provide execution capacity after the plan is agreed, but the advisory relationship comes first: I am there to help management and the sponsor make better operating decisions, not to sell a bench.
GTM value creation for portfolio companies works when it becomes an operating cadence with clear tradeoffs. Pick the constraint, define the evidence, sequence the moves, and make the revenue system easier to inspect. That is how GTM stops being a board slide and starts becoming value creation.